skip to main | skip to sidebar

The Health, Drug, Prescription, and GMP Supersite

Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.

Sunday, June 7, 2020

COVID-19 - How To Protect Yourself And Others - CDC.gov

The pandemic is not over yet!


The CDC tells us:

How to Protect Yourself & Others



Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
Designated Rep Certification Class
CA Designated Representative Training Program
California Designated Representative Training Program
California HMDR Exemptee Training
Exemptee Certification Class
FL CDR Exam Prep
SkillsPlus Intl Inc. - The Leader in Compliance Training
The Health, Drug, Prescription, and GMP Supersite Gift Store 

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted by Austin Lee at 5:57 AM
Labels: cdc, COVID, guidelines, recommendations

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

From SkillsPlus International Inc.

Loading...
  • Home
  • SkillsPlus Intl Inc - The Leader in QSR & GMP Training
  • Popular FDA, cGMP, QSR, & GMP Training Courses
  • The Best Exemptee & Designated Representative Training Courses - Online Self-Study
  • CA HMDR Exemptee Certification Class
  • California Exemptee Certification - State Approved
  • The Exemptee Institute
  • The Designated Representative Institute
  • SkillsPlus Intl Inc Blog
  • Home Medical Device Retail - California HMDR Exemptee Training Certification Course
  • Designated Representative Online Training Courses

California Designated Representative Training


Designated Representative Wholesaler Training Course

Designated Representative 3PL Training Course

Designated Representative Reverse Distributor Course


SkillsPlus International Inc. is the ONLY training provider approved by the California State Board of Pharmacy to offer California Designated Representative training programs for wholesalers, 3PL, and reverse distributors. Nearly 10,000 students have taken our state license-related training courses! #2026 #2027 #2028

CA Designated Rep 3PL Course

CA Designated Rep 3PL Course
California Designated Representative 3PL Online Training Course. #2026

The Best Exemptee Training



Sign-up for Exemptee training now!


California HMDR Exemptee license online training certification class for home medical device retailers. Earns a course completion certificate accepted by the California Department of Public Health - Food and Drug Branch. We've added something new, closed captioning. Students can read what the course instructor is teaching. Nearly 10,000 students have taken our state license-related training courses! This feature helps ESL (English as a second language) students, and hard of hearing students. #2026 #2027 #2028

CGMP Online Training Courses

CGMP Online Training Courses
Current Good Manufacturing Practice Training: A New Generation Series - CGMP Online Courses

GMP Trainer Courses

GMP Trainer Courses
GMP Trainer Awareness, Certification, and Master Trainer Courses

Root Cause Analysis - cGMP Training

Root Cause Analysis - cGMP Training
cGMP Training - Online Self-Study Course - Root Cause - Investigation Reports

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments
Subscribe to The Health, Drug, Prescription, and GMP Supersite by Email

Blog List

  • Drug Channels
    The Direct-to-Patient Opportunity: Evolving Pharma’s DTP Strategy for Lasting Patient Engagement
    2 hours ago
  • Pharmafile
    ProBioGen secures extended GMP authorisation for viral manufacturing facility
    2 hours ago
  • GEN Biotech News
    Single-Cell Method Reveals On- and Off-Target Effects of Cas9 Edits on Gene Expression
    3 hours ago
  • All Kaiser Health News
    These Governors-Elect Campaigned on Expanding Medicaid. It Won’t Be Easy.
    3 hours ago
  • Medtech Insight
    The Insight Room: Separating AI Innovation From Theater at the Point of Care
    4 hours ago
  • Science-Based Medicine
    Should Democrats work with Robert F. Kennedy Jr.?
    5 hours ago
  • Wellness Blog - NY Times
    Research Stalls for a Year Into a Cancer That Kills Children in a Year
    13 hours ago
  • Government Executive
    Legacy tech issue led to FAA’s nationwide ground stop
    20 hours ago
  • eLearning Industry
    Rise of AI-Powered Chatbot in eLearning App Development
    1 day ago
  • Food Poison Journal
    Two California E. coli O157 Outbreaks, Three Families: Brookshire Farms and Capitola Beach. What We Know, What We Do Not, and the Records We Have Asked For
    1 day ago
  • Marler Blog
    Brookshire Farms E. coli Outbreak Spreads to a San Luis Obispo Preschool: What a Secondary Case Is, How Common It Is and Where It Happens
    1 day ago
  • FDA What's New: Drugs
    FDA Approves First Drug to Treat Adults with Primary Membranous Nephropathy
    2 days ago
  • JD Supra Law News
    Anthem’s $12.9 Million ERISA Settlement: What Behavioral Health Providers Should Know
    2 days ago
  • Medscape Today Headlines
    Obesity Week 2026
    2 days ago
  • FierceBiotech: Medtech
    American Cancer Society updates prostate cancer screening guidance
    2 days ago
  • Pharmalot – STAT
    STAT+: Up and down the ladder: The latest comings and goings
    2 days ago
  • BioPharma Dive - Latest News
    Novo submits sickle cell drug; Flagship, Gates Foundation deepen ties
    2 days ago
  • BioPharma Dive
    Novo submits sickle cell drug; Flagship, Gates Foundation deepen ties
    2 days ago
  • Pharmaceutical Commerce
    2 days ago
  • Clarkston Consulting
    Developing an Indirect Sales Planning Roadmap for a Frozen Foods Manufacturer
    3 days ago
  • FiercePharma
    FDA rejects Summit’s ivonescimab, derailing US arrival of much-hyped PD-1xVEGF class
    3 days ago
  • Drug & Device Law
    Maybe the Ninth Circuit Is Not So On Board With the Rule 702 Amendments After All
    3 days ago
  • FierceBiotech
    Big Pharma-backed Seawolf surfaces with $100M to hand, $1.2B Sanofi DNA med pact
    4 days ago
  • CNBC Health Care
    Feds arrest top official of healthcare company, alleging illegal drug importation
    4 days ago
  • Asbestos and Mesothelioma News
    Moffitt Takes Aim at Lung Cancer Screening Gap With Mobile Program
    4 days ago
  • FDA - Press Releases
    FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk
    6 days ago
  • The Incidental Economist
    A Halloween History of Who Gets to Use the Dead
    2 weeks ago
  • World Pharma - Breaking News
    Researchers discover Achilles' heel of antibiotic-resistant bacteria
    3 weeks ago
  • Pharmafile - Mfg & Production
    UK immunoglobulin supply faces growing pressure, report warns
    5 weeks ago
  • Clinical Correlations
    Playing God? The God Committee and the History of Hemodialysis
    1 month ago
  • Pharma IQ Regulatory-Legal
    AI-Driven Productivity Gains: Transforming Pharma Supply Chain Efficiency
    2 months ago
  • Biotech Blog
    The China Patent Linkage System Changed in Ways Most US IP Teams Haven’t Noticed
    2 months ago
  • The Compliance and Ethics Blog
    Compliance and Compounding: A Healthcare Fraud Trend to Watch For
    4 months ago
  • Ted Eytan, MD
    Catania, Sicily
    4 months ago
  • Quality Matters
    Managing mutagenic impurities: Stakeholders seek clarity, consistency, and practical tools for implementation
    5 months ago
  • FDA - Health Fraud
    Umary contains hidden drug ingredients
    7 months ago
  • Eye on FDA
    Is cooking with olive oil really beneficial for your health? Expert Answers
    7 months ago
  • NPR Blogs: Shots - Health News Blog
    Flu shot recommendation for kids dropped just as the illness rages
    10 months ago
  • Healthcare Packaging
    Practical Waste Recycling at the Hospital Level: What Are the Odds?
    11 months ago
  • 33 Charts
    The AI coding arms race
    1 year ago
  • Mobihealthnews
    Mendaera gets FDA 510(k) clearance for handheld robotic system
    1 year ago
  • SkillsPlus International Info
    FDA Rushed Out AI Tool
    1 year ago
  • The Health, Drug, Prescription, and GMP Supersite
    Designated Representative Training - California | State-Approved
    1 year ago
  • Modern Healthcare News
    Meet the Administration for a Healthy America, HHS' newest agency
    1 year ago
  • Designated Representative and Exemptee
    Designated Representative Training | Board-Approved Courses | Recommended
    1 year ago
  • FDA – Policy & Medicine
    FDA Releases Draft Guidance on the Accelerated Approval Process
    1 year ago
  • BioPharma-Reporter RSS
    Inhibikase to pause development of Parkinson’s drug
    1 year ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    1 year ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    1 year ago
  • BioSpace Regulatory News
    FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm
    2 years ago
  • Healthy Travel Blog
    Hello world!
    2 years ago
  • Quality Digest - FDA Compliance
    Nine Strategies for Effective Internal Audits
    2 years ago
  • Designated Representative Training Courses
    The Only Board-Approved California Designated Representative Training Programs For ...
    2 years ago
  • HMDR Exemptee Online Training
    California HMDR Exemptee Online Training Certification Course
    2 years ago
  • Medgadget
    Plant-Based Soft Medical Robots
    2 years ago
  • Drug Injury Watch
    Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening
    3 years ago
  • Golf Foodie
    More women in the U.S. are drinking themselves to death, research finds
    3 years ago
  • PharmaPhorum News
    Patient adherence – the key to restoring trust in pharma
    3 years ago
  • Pharma Manufacturing
    How pharma can overcome inflation
    4 years ago
  • Pharmaceutical Industry | Processing & Engineering: Knowledge, News and Analysis | Pharmaceutical Manufacturing
    How pharma can overcome inflation
    4 years ago
  • CA Designated Rep Training
    Recommended! California Designated Representative Online Training Courses
    7 years ago
Show 5 Show All

Blog Archive

  • ►  2025 (1)
    • ►  June (1)
  • ►  2024 (5)
    • ►  August (1)
    • ►  July (1)
    • ►  May (1)
    • ►  March (2)
  • ►  2023 (6)
    • ►  December (1)
    • ►  October (2)
    • ►  July (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2022 (26)
    • ►  November (3)
    • ►  October (1)
    • ►  August (2)
    • ►  July (3)
    • ►  June (4)
    • ►  May (3)
    • ►  April (3)
    • ►  March (1)
    • ►  February (3)
    • ►  January (3)
  • ►  2021 (17)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  September (2)
    • ►  July (1)
    • ►  April (1)
    • ►  March (1)
    • ►  February (2)
    • ►  January (4)
  • ▼  2020 (27)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (4)
    • ►  August (2)
    • ►  July (2)
    • ▼  June (2)
      • California Designated Representative Training Cour...
      • COVID-19 - How To Protect Yourself And Others - CD...
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2019 (28)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (2)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (2)
    • ►  April (1)
    • ►  February (3)
  • ►  2018 (6)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2017 (14)
    • ►  November (1)
    • ►  October (2)
    • ►  August (1)
    • ►  July (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  January (5)
  • ►  2016 (32)
    • ►  December (6)
    • ►  November (4)
    • ►  October (2)
    • ►  September (2)
    • ►  August (2)
    • ►  July (3)
    • ►  June (1)
    • ►  May (3)
    • ►  March (4)
    • ►  February (2)
    • ►  January (3)
  • ►  2015 (68)
    • ►  December (2)
    • ►  November (7)
    • ►  October (10)
    • ►  September (5)
    • ►  August (1)
    • ►  July (6)
    • ►  June (7)
    • ►  May (5)
    • ►  April (3)
    • ►  March (3)
    • ►  February (13)
    • ►  January (6)
  • ►  2014 (105)
    • ►  December (10)
    • ►  November (9)
    • ►  October (1)
    • ►  September (9)
    • ►  August (4)
    • ►  July (6)
    • ►  June (11)
    • ►  May (10)
    • ►  April (10)
    • ►  March (11)
    • ►  February (15)
    • ►  January (9)
  • ►  2013 (127)
    • ►  December (7)
    • ►  November (14)
    • ►  October (7)
    • ►  September (11)
    • ►  August (7)
    • ►  July (9)
    • ►  June (9)
    • ►  May (6)
    • ►  April (8)
    • ►  March (22)
    • ►  February (9)
    • ►  January (18)
  • ►  2012 (172)
    • ►  December (8)
    • ►  November (20)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (22)
    • ►  June (23)
    • ►  May (17)
    • ►  April (17)
    • ►  March (12)
    • ►  February (13)
    • ►  January (18)
  • ►  2011 (116)
    • ►  December (8)
    • ►  November (15)
    • ►  October (4)
    • ►  September (18)
    • ►  August (9)
    • ►  July (6)
    • ►  June (8)
    • ►  May (9)
    • ►  April (5)
    • ►  March (13)
    • ►  February (10)
    • ►  January (11)
  • ►  2010 (106)
    • ►  December (14)
    • ►  November (8)
    • ►  October (5)
    • ►  September (6)
    • ►  August (10)
    • ►  July (5)
    • ►  June (9)
    • ►  May (11)
    • ►  April (5)
    • ►  March (11)
    • ►  February (10)
    • ►  January (12)
  • ►  2009 (192)
    • ►  December (11)
    • ►  November (11)
    • ►  October (15)
    • ►  September (13)
    • ►  August (10)
    • ►  July (19)
    • ►  June (16)
    • ►  May (16)
    • ►  April (17)
    • ►  March (16)
    • ►  February (19)
    • ►  January (29)
  • ►  2008 (245)
    • ►  December (32)
    • ►  November (39)
    • ►  October (39)
    • ►  September (33)
    • ►  August (52)
    • ►  July (50)

Disclaimer & Privacy Policy

All data and information provided on this site is for informational purposes only. Drughealth.blogspot.com makes no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

SkillsPlus International Inc.

SkillsPlus International Inc.
SkillsPlus International Inc. Logo